New York State Common Retirement Fund Krystal Biotech, Inc. Transaction History

New York State Common Retirement Fund

  • $73.9 Billion
  • Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 25,863 shares of KRYS stock, worth $3.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,863
Previous 28,381 8.87%
Holding current value
$3.95 Million
Previous $5.21 Million 9.67%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$174.7 - $213.66 $439,894 - $537,995
-2,518 Reduced 8.87%
25,863 $4.71 Million
Q2 2024

Jul 31, 2024
BUY
$153.12 - $183.64 $1.59 Million - $1.9 Million
10,353 Added 57.43%
28,381 $5.21 Million
Q1 2024

May 07, 2024
BUY
$108.01 - $179.35 $327,810 - $544,327
3,035 Added 20.24%
18,028 $3.21 Million
Q4 2023

Feb 01, 2024
SELL
$96.0 - $128.29 $680,736 - $909,704
-7,091 Reduced 32.11%
14,993 $1.86 Million
Q3 2023

Nov 07, 2023
BUY
$108.51 - $130.22 $7,161 - $8,594
66 Added 0.3%
22,084 $2.56 Million
Q2 2023

Aug 07, 2023
SELL
$78.48 - $130.32 $190,157 - $315,765
-2,423 Reduced 9.91%
22,018 $2.59 Million
Q1 2023

May 02, 2023
SELL
$72.39 - $84.27 $340,088 - $395,900
-4,698 Reduced 16.12%
24,441 $1.96 Million
Q4 2022

Jan 30, 2023
SELL
$63.14 - $79.9 $505 - $639
-8 Reduced 0.03%
29,139 $2.31 Million
Q3 2022

Nov 08, 2022
BUY
$64.85 - $82.4 $112,385 - $142,799
1,733 Added 6.32%
29,147 $2.03 Million
Q2 2022

Aug 04, 2022
BUY
$48.93 - $73.47 $17,027 - $25,567
348 Added 1.29%
27,414 $1.8 Million
Q1 2022

May 05, 2022
BUY
$51.99 - $72.11 $148,015 - $205,297
2,847 Added 11.76%
27,066 $1.8 Million
Q4 2021

Feb 02, 2022
SELL
$39.81 - $88.24 $77,231 - $171,185
-1,940 Reduced 7.42%
24,219 $1.69 Million
Q3 2021

Nov 02, 2021
BUY
$52.01 - $71.77 $8,373 - $11,554
161 Added 0.62%
26,159 $1.37 Million
Q2 2021

Aug 02, 2021
BUY
$62.14 - $81.82 $212,829 - $280,233
3,425 Added 15.17%
25,998 $1.77 Million
Q4 2020

Feb 08, 2021
BUY
$40.64 - $61.38 $95,991 - $144,979
2,362 Added 11.69%
22,573 $1.35 Million
Q2 2020

Aug 07, 2020
BUY
$37.03 - $60.0 $88,872 - $144,000
2,400 Added 13.47%
20,211 $837,000
Q1 2020

May 06, 2020
BUY
$35.02 - $65.64 $80,581 - $151,037
2,301 Added 14.84%
17,811 $770,000
Q4 2019

Feb 05, 2020
BUY
$33.17 - $65.23 $16,585 - $32,615
500 Added 3.33%
15,510 $859,000
Q2 2019

Aug 09, 2019
BUY
$27.2 - $41.2 $229,350 - $347,398
8,432 Added 128.18%
15,010 $604,000
Q1 2019

May 08, 2019
SELL
$19.86 - $32.9 $21,786 - $36,091
-1,097 Reduced 14.29%
6,578 $216,000
Q4 2018

Feb 08, 2019
BUY
$15.03 - $25.38 $115,355 - $194,791
7,675 New
7,675 $159,000

Others Institutions Holding KRYS

# of Institutions
309
Shares Held
24.3M
Call Options Held
483K
Put Options Held
364K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $3.92B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email